Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · IEX Real-Time Price · USD
11.72
+0.04 (0.34%)
At close: May 2, 2024, 4:00 PM
11.96
+0.24 (2.05%)
After-hours: May 2, 2024, 6:48 PM EDT
Dynavax Technologies Employees
Dynavax Technologies had 408 employees on December 31, 2023. The number of employees increased by 57 or 16.24% compared to the previous year.
Employees
408
Change (1Y)
57
Growth (1Y)
16.24%
Revenue / Employee
$569,324
Profits / Employee
-$15,659
Market Cap
1.53B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 408 | 57 | 16.24% |
Dec 31, 2022 | 351 | 40 | 12.86% |
Dec 31, 2021 | 311 | 66 | 26.94% |
Dec 31, 2020 | 245 | 14 | 6.06% |
Dec 31, 2019 | 231 | -18 | -7.23% |
Dec 31, 2018 | 249 | 79 | 46.47% |
Dec 31, 2017 | 170 | -81 | -32.27% |
Dec 31, 2016 | 251 | 17 | 7.26% |
Dec 31, 2015 | 234 | 37 | 18.78% |
Dec 31, 2014 | 197 | 46 | 30.46% |
Dec 31, 2013 | 151 | -16 | -9.58% |
Dec 31, 2012 | 167 | 17 | 11.33% |
Dec 31, 2011 | 150 | 22 | 17.19% |
Dec 31, 2010 | 128 | -2 | -1.54% |
Dec 31, 2009 | 130 | -25 | -16.13% |
Dec 31, 2008 | 155 | -18 | -10.40% |
Dec 31, 2007 | 173 | 20 | 13.07% |
Dec 31, 2006 | 153 | 76 | 98.70% |
Dec 31, 2005 | 77 | 6 | 8.45% |
Dec 31, 2004 | 71 | 27 | 61.36% |
Dec 31, 2003 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Warby Parker | 3,491 |
LeMaitre Vascular | 630 |
ADMA Biologics | 624 |
InMode | 581 |
Arcus Biosciences | 577 |
Ardelyx | 267 |
Day One Biopharmaceuticals | 155 |
Neumora Therapeutics | 124 |
DVAX News
- 8 days ago - Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 - PRNewsWire
- 2 months ago - Dynavax to Present at TD Cowen's 44th Annual Health Care Conference - PRNewsWire
- 2 months ago - Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance - PRNewsWire
- 3 months ago - Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024 - PRNewsWire
- 4 months ago - Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights - PRNewsWire
- 4 months ago - Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - 20 favorite small-cap stocks for 2024 among Wall Street analysts - Market Watch
- 5 months ago - Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference - PRNewsWire